Afficher la notice abrégée
dc.contributor.author |
Kherbiche, Fatma |
|
dc.date.accessioned |
2018-11-29T09:55:47Z |
|
dc.date.available |
2018-11-29T09:55:47Z |
|
dc.date.issued |
2016 |
|
dc.identifier.uri |
http://e-biblio.univ-mosta.dz/handle/123456789/3608 |
|
dc.description.abstract |
In recent years considerable progress has been made in order to guarantee maximum safety
transfused. However, a residual risk remains, that of contracting a viral disease by
transfusion and that, despite donor selection measures. The risk arises when the donor is
seroconversion phase, a period when biological markers of viral pathology are
undetectable by the usual methods of serological diagnostics
The results show that out of a population of 96 hemodialysis recipients percentages were:
HIV0%; HBs25% .HCV.6%. TPHA .33% for men compared to HIV0%; HBs75%
.HCV.67%. TPHA.3% in women. Nevertheless, these results indicate that the study
population was infected with syphilis (4%), HCV (19%), HBs (4%) and HIV (0%).
Have an efficient health system for screening for disease transmissible by blood is a good
thing, the organization of this system to a preventive struggle and psychological support to
patients regardless of the test results, without forgetting that the latter must be
individualized because there is no standard method that would be suitable in all situations. |
en_US |
dc.language.iso |
fr |
en_US |
dc.title |
banque de sang et risques des maladies transfusionnelles |
en_US |
dc.type |
Other |
en_US |
Fichier(s) constituant ce document
Ce document figure dans la(les) collection(s) suivante(s)
Afficher la notice abrégée